Michele Nichelatti

Dr. Michele Nichelatti


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2025 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
FBF. Barbosa
F. Barbosa
Paolo AseniPaolo Aseni
Paolo Aseni
MVMaurizio Vertemati
Maurizio Vertemati
CBChiara Becchetti
Chiara Becchetti
AAA. Airoldi
A. Airoldi
FCF. C. Carnevale
F. C. Carnevale

Verified
Journal Article
Open access
PDF file
SCSara Castiglioni
Sara Castiglioni
VMVincenzo Miranda
Vincenzo Miranda
ACAlessandra Cazzaniga
Alessandra Cazzaniga
MCMarilena Campanella
Marilena Campanella
MNMichele Nichelatti
Michele Nichelatti
JMJeanette Maier
Jeanette Maier
Since interferon-γ (IFN-γ) tunes both innate and adaptive immune systems, it was expected to enter clinical practice as an immunomodulatory drug. However, the use of IFN-γ has been limited by its dose-dependent side effects. Low-dose medicine, which is emerging as a novel strategy to treat diseases, might circumvent this restriction. Several clinical studies have proved the efficacy of therapies with a low dose of cytokines subjected to kinetic activation, while no in vitro data are available. To fill this gap, we investigated whether low concentrations, in the femtogram range, of kinetically activated IFN-γ modulate the behavior of Jurkat cells, a widely used experimental model that has importantly contributed to the present knowledge about T cell signaling. In parallel, IFN-γ in the nanogram range was used and shown to activate Signal transducer and activator of transcription (STAT)-1 and then to induce suppressor of cytokine signaling-1 (SOCS-1), which inhibits downstream signaling. When added together, femtograms of IFN-γ interfere with the transduction cascade activated by nanograms of IFN-γ by prolonging the activation of STAT-1 through the downregulation of SOCS-1. We conclude that femtograms of IFN-γ exert an immunomodulatory action in Jurkat cells.

31 May 2007 in Leukemia Research
Verified
Journal Article
Closed access
AMA. Molteni
A. Molteni
GNG. Nador
G. Nador
MMM. Montillo
M. Montillo
ANA. Nosari
A. Nosari
MNMichele Nichelatti
Michele Nichelatti
EME. Morra
E. Morra

31 May 2011 in Leukemia Research
Verified
Journal Article
Closed access
MRM. Riva
M. Riva
AMA. Molteni
A. Molteni
RGR. Greco
R. Greco
MNMichele Nichelatti
Michele Nichelatti
EME. Morra
E. Morra